• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchSilence Therapeutics
    Picture of Silence Therapeutics logo

    SLNCF — Silence Therapeutics News Story

    $6.370.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapMomentum Trap
    • Market Cap
      $902.88m
    • Enterprise Value
      $830.82m
    • Revenue
      $0.56m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • SLNCF Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    SLNCF Dividends
    All News

    NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:27 AM

    Picture of Silence Therapeutics logoSilence Therapeutics
    22/06/2022 15:27
    NASDAQ TRADE HALT  SLN.O  VOLATILITY TRADING PAUSE AT 10:27 AM
    

    Recent news on Silence Therapeutics

    See all news
    • Brief: Silence Therapeutics Reports Second Quarter 2025 Financial Results And Recent Business Highlights

      07/08/2025 13:04
    • Brief: Silence Therapeutics files for stock shelf, size not disclosed

      22/10/2024 22:32
    • Brief: Silence Therapeutics Announces Positive Results From Ongoing Sanreco Phase 1 Study

      27/06/2024 12:38
    • Brief: Silence Therapeutics Announces Positive Topline 48-Week Data From Phase 2 Study Of Zerlasiran In Patients With Elevated Lipoprotein

      20/06/2024 13:21
    • Brief: Silence Therapeutics PLC Files For Resale Of Up To 5.71 Million Shares By The Selling Securityholders - SEC Filing

      07/05/2024 22:15

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.